CNS Clinical Trials: Suicidality and Data Collection: Workshop Summary (Paperback)Forum on Neuroscience and Nervous System Disorders (author), Board on Health Sciences Policy (author), Institute of Medicine (author), Bruce Altevogt (editor), Miriam Davis (editor), Sarah Hanson (editor)
Paperback 88 Pages / Published: 22/01/2011
- Publisher out of stock
The Food and Drug Administration (FDA) now requires that all clinical trials for drugs that affect the central nervous system--including psychiatric drugs--are assessed for whether that drug might cause suicidal ideation or behavior. The Institute of Medicine's (IOM) Forum on Neuroscience and Nervous System Disorders hosted a meeting on June 26, 2009, to discuss the FDA's new policy and how to analyze best whether suicidal thoughts predict actual suicidal behavior in the near future.
Publisher: National Academies Press
Number of pages: 88
Dimensions: 229 x 152 mm
You may also be interested in...
Please sign in to write a review
Simply reserve online and pay at the counter when you collect. Available in shop from just two hours, subject to availability.
Thank you for your reservation
Your order is now being processed and we have sent a confirmation email to you at
When will my order be ready to collect?
Following the initial email, you will be contacted by the shop to confirm that your item is available for collection.
Call us on or send us an email at
Unfortunately there has been a problem with your order
Please try again or alternatively you can contact your chosen shop on or send us an email at